THE PATHOGENESIS OF SEPTIC SHOCK

[1] Kieft, Hoepelman, Zhou, Rozenberg-Arska, Struyvenberg, Verhoef, The sepsis syndrome in a Dutch university hospital, Arch Intern Med, 153, pp. 2241-2247, (1993)

[2] Marks, Marks, Luce, Et al., Plasma tumour necrosis factor in patients with septic shock, Am Rev Respir Dis, 141, pp. 94-97, (1990)

[3] Krausz, Cohen, Shock, Oxford Textbook of Pathology, pp. 540-551, (1992)

[4] de Azavedo, Animal models for toxic shock syndrome: an overview, Rv Infect Dis, 11, pp. S205-S209, (1989)

[5] Himanen, Pyhala, Olander, Et al., Biological activities of lipoteichoic acid and peptidoglycan-teichoic acid of Bacillus subtilis 168 (Marburg), J Gen Microbiol, 139, pp. 2659-2665, (1993)

[6] Kim, Watson, A purified group A streptococcal pyrogenic exotoxin, J Exp Med, 131, pp. 611-628, (1970)

[7] Martich, Danner, Ceska, Suffredini, Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents, J Exp Med, 173, pp. 1021-1024, (1991)

[8] Timmerman, Mattson, Martinez-Martinez, Et al., Induction of release of tumour necrosis factor from human monocytes by staphylococci and staphycoccal peptidoglycans, Infect Immun, 61, pp. 4167-4172, (1993)

[9] Lynn, Golenbock, Lipopolysaccharide antagonists, Immunol Today, 13, pp. 271-276, (1992)

[10] Webb, Gascoigne, T-cell activation by bacterial super-antigens, Curr Opinion Immunol, 6, pp. 467-475, (1994)

[1] Kieft, Hoepelman, Zhou, Rozenberg-Arska, Struyvenberg, Verhoef, The sepsis syndrome in a Dutch university hospital, Arch Intern Med, 153, pp. 2241-2247, (1993)

[2] Marks, Marks, Luce, Et al., Plasma tumour necrosis factor in patients with septic shock, Am Rev Respir Dis, 141, pp. 94-97, (1990)

[3] Krausz, Cohen, Shock, Oxford Textbook of Pathology, pp. 540-551, (1992)

[4] de Azavedo, Animal models for toxic shock syndrome: an overview, Rv Infect Dis, 11, pp. S205-S209, (1989)

[5] Himanen, Pyhala, Olander, Et al., Biological activities of lipoteichoic acid and peptidoglycan-teichoic acid of Bacillus subtilis 168 (Marburg), J Gen Microbiol, 139, pp. 2659-2665, (1993)

[6] Kim, Watson, A purified group A streptococcal pyrogenic exotoxin, J Exp Med, 131, pp. 611-628, (1970)

[7] Martich, Danner, Ceska, Suffredini, Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents, J Exp Med, 173, pp. 1021-1024, (1991)

[8] Timmerman, Mattson, Martinez-Martinez, Et al., Induction of release of tumour necrosis factor from human monocytes by staphylococci and staphycoccal peptidoglycans, Infect Immun, 61, pp. 4167-4172, (1993)

[9] Lynn, Golenbock, Lipopolysaccharide antagonists, Immunol Today, 13, pp. 271-276, (1992)

[10] Webb, Gascoigne, T-cell activation by bacterial super-antigens, Curr Opinion Immunol, 6, pp. 467-475, (1994)